Osteoporosis Imaging: Bone Density Testing & Fracture Risk Assessment

Quick Answer: Osteoporosis is a silent disease that weakens bones and increases fracture risk, but bone density testing (DXA scan) can detect bone loss before fractures occur. DXA (dual-energy X-ray absorptiometry) is the gold standard for measuring bone mineral density, using minimal radiation—less than a chest X-ray—to assess bone strength. Your results are reported as a T-score that compares your bone density to young healthy adults: -1.0 and above is normal, -1.0 to -2.5 indicates osteopenia (mild bone loss), and below -2.5 indicates osteoporosis. The National Osteoporosis Foundation recommends screening for women over 65 and men over 70, along with younger individuals with risk factors. Early detection through imaging allows treatment that can prevent debilitating fractures.

Understanding bone density testing and fracture risk assessment helps patients and doctors make informed decisions about bone health, fracture prevention, and osteoporosis treatment.

Osteoporosis is a bone disease characterized by:

• Decreased bone density: Bones become less dense and more porous
• Disrupted bone architecture: The microscopic structure of bone deteriorates
• Increased fracture risk: Weakened bones break more easily

The silent epidemic:

• 10 million Americans have osteoporosis
• 44 million Americans have osteopenia (low bone mass)
• 1 in 2 women and 1 in 4 men over 50 will break a bone due to osteoporosis
• 2 million osteoporotic fractures occur annually in the U.S.

Why osteoporosis matters:

• Fractures cause disability: Hip fractures often lead to loss of independence
• Increased mortality: Up to 20-25% of hip fracture patients die within a year
• Economic burden: Osteoporosis causes $57 billion in annual costs in the U.S.
• Preventable: Early detection and treatment can prevent many fractures

Risk factors for osteoporosis:

• Female gender: Women lose bone more rapidly after menopause
• Age: Risk increases with age
• Family history: Genetics play a significant role
• Low body weight: Small, thin-boned frame
• Previous fracture: Having had one fracture doubles risk of another
• Smoking: Tobacco use decreases bone density
• Excessive alcohol: More than 2 drinks daily for men, 1 for women
• Certain medications: Long-term steroids, proton pump inhibitors, some seizure medications
• Medical conditions: Rheumatoid arthritis, hyperthyroidism, celiac disease, CKD

What Is a DXA Scan?

DXA (dual-energy X-ray absorptiometry), also called DEXA or bone density scan, is:

• The gold standard: For diagnosing osteoporosis and assessing fracture risk
• Quick and painless: Takes 10-20 minutes with no discomfort
• Low radiation: Uses less radiation than a chest X-ray (approximately 0.001-0.01 mSv)
• Widely available: Available at hospitals, imaging centers, and some medical offices

How DXA works:

1. Two X-ray beams: Different energy levels pass through bone
2. Bone absorption: Bone absorbs one beam more than the other
3. Density calculation: The difference between the two beams measures bone mineral density
4. Comparison: Your bone density is compared to reference values

What DXA measures:

• Bone mineral density (BMD): The amount of mineral in bone tissue
• T-score: Comparison to young healthy adults (same gender, peak bone mass)
• Z-score: Comparison to age-matched adults (same gender, age, ethnicity)
• FRAX score: 10-year fracture risk calculation (uses DXA + clinical risk factors)

DXA Scan Sites

Standard measurement sites:

• Hip (proximal femur): Including femoral neck and total hip regions
• Lumbar spine (L1-L4): Lower back vertebrae

Alternative sites (when hip/spine can't be measured):

• Forearm (radius): Wrist measurement
• Heel: Portable heel scanners for screening

Why hip and spine:

• Hip: Fracture risk correlates with hip BMD; hip fractures cause the most morbidity
• Spine: Vertebral fractures are common; spine BMD predicts fracture risk
• Both sites: Some patients have discordance—different T-scores at different sites

Interpreting DXA Results

T-score classification (World Health Organization criteria):

• Normal: T-score -1.0 or higher (bone density within 1 standard deviation of young adult mean)
• Osteopenia (low bone mass): T-score between -1.0 and -2.5 (bone density 1-2.5 standard deviations below young adult mean)
• Osteoporosis: T-score -2.5 or lower (bone density more than 2.5 standard deviations below young adult mean)

What the scores mean:

• Each 1 standard deviation decrease: Approximately doubles fracture risk
• T-score -1.0: About 2x increased fracture risk compared to normal
• T-score -2.0: About 4x increased fracture risk
• T-score -3.0: About 8x increased fracture risk

Z-score interpretation:

• Comparison to age-matched peers: If your Z-score is significantly below zero (-2.0 or lower), something besides aging may be causing bone loss (medications, medical conditions)

Example DXA report:

Patient: Female, age 65
Site          BMD (g/cm²)   T-score   Z-score
Lumbar Spine    0.850        -2.1      -0.8
Femoral Neck    0.650        -2.6      -1.2
Total Hip       0.720        -2.0      -0.9

Diagnosis: Osteoporosis (based on femoral neck T-score of -2.6)
10-year major osteoporotic fracture risk: 18% (high risk)

”

Key Finding: The FRAX (Fracture Risk Assessment Tool) calculation combines DXA T-scores with clinical risk factors (age, sex, weight, fracture history, steroid use, smoking, rheumatoid arthritis, secondary osteoporosis, alcohol) to estimate 10-year fracture probability. Treatment is often recommended when 10-year major fracture risk exceeds 20% or hip fracture risk exceeds 3%.

Source: World Health Organization, FRAX Tool Reference: Assessment of Osteoporosis at the Primary Health-Care Level

Vertebral Fracture Assessment (VFA)

What it is: Lateral spine X-rays obtained during DXA scanning to detect vertebral compression fractures.

Why VFA matters:

• Silent fractures: Up to 2/3 of vertebral fractures don't cause pain
• Undiagnosed osteoporosis: Presence of vertebral fracture indicates osteoporosis regardless of BMD
• Fracture prediction: Having one vertebral fracture increases risk of future fractures 5x
• Changes management: Finding vertebral fractures may change treatment decisions

Who should have VFA (International Society for Clinical Densitometry recommendations):

• Women with osteoporosis by T-score
• Women and men receiving long-term glucocorticoid therapy
• Postmenopausal women with height loss >4cm (1.6 inches)
• Postmenopausal women with historical height loss >2cm (0.8 inches)
• Men with T-score ≤ -2.0
• Patients with findings on spinal X-rays suggesting vertebral fracture

VFA advantages:

• Convenience: Performed during DXA scan—no separate appointment
• Low radiation: Minimal additional radiation
• Quick: Adds only a few minutes to the DXA appointment

Plain X-Rays for Fracture

Indications:

• Acute back pain: Evaluating for new vertebral compression fracture
• Known vertebral fracture: Determining age of fracture (acute vs. chronic)
• Painful fractures: When fracture location is unclear

Findings in vertebral compression fracture:

• Anterior wedge: Front of vertebra compressed
• Biconcave deformity: Both ends compressed
• Crush fracture: Entire vertebra compressed

Limitations:

• Radiation: Higher radiation than DXA
• Interobserver variability: Different radiologists may disagree on presence/severity
• Doesn't measure BMD: Shows fractures but not bone density

CT and MRI for Vertebral Fractures

CT for vertebral fractures:

• Detailed bone anatomy: Shows fracture anatomy better than X-ray
• 3D assessment: Can assess fracture alignment and stability
• Ablation/kyphoplasty planning: Planning vertebroplasty procedures

MRI for vertebral fractures:

• Differentiates acute vs. chronic: Edema indicates acute fracture
• Assesses for malignancy: Can detect pathologic fractures from tumor
• Evaluates spinal canal: Identifies nerve compression from fracture fragments

When CT/MRI is used:

• Atypical fractures: Unusual fracture patterns
• Neurologic symptoms: Nerve compression or spinal cord involvement
• Pre-surgical planning: Before vertebroplasty or kyphoplasty
• Multiple myeloma evaluation: Looking for other bone lesions

High-Resolution Peripheral Quantitative CT (HR-pQCT)

What it is: Specialized CT measuring bone density and microarchitecture at peripheral sites (radius, tibia).

Research use:

• Bone microarchitecture: Assesses trabecular and cortical bone structure
• Bone strength prediction: May better predict fracture risk than DXA
• Research tool: Currently primarily used in research, not routine clinical care

Limitations:

• Limited availability: Very few centers have this technology
• Research use: Not standard for clinical osteoporosis diagnosis
• Extremity only: Measures wrist/ankle, not hip/spine

Screening Recommendations

National Osteoporosis Foundation screening guidelines:

Women:

• Age 65 and older: Universal screening
• Age 50-64: Screen if risk factors present
• Under age 50: Screen based on risk factors

Men:

• Age 70 and older: Universal screening
• Age 50-69: Screen if risk factors present
• Under age 50: Screen based on risk factors

Risk factors that warrant earlier testing:

• Fracture after age 50: Any fragility fracture (fracture from minor trauma)
• Parental hip fracture: Family history of hip fracture
• Rheumatoid arthritis: Inflammatory bone loss
• Current smoking: Tobacco use decreases bone density
• Low body weight: Body weight <127 lbs (58 kg)
• Glucocorticoid use: Long-term steroid therapy (prednisone ≥5mg/day for ≥3 months)
• Other medical conditions: Hyperparathyroidism, hyperthyroidism, untreated hypogonadism in men and women

Monitoring Testing Intervals

How often to repeat DXA:

• Normal BMD: Repeat in 10-15 years (postmenopausal women) or at routine screening intervals
• Osteopenia: Repeat in 2-5 years depending on risk factors
• On osteoporosis treatment: Repeat every 1-2 years to monitor response
• Long-term glucocorticoid therapy: Repeat every 1-2 years

Factors affecting repeat interval:

• Age: More frequent monitoring in older patients
• Current BMD: More frequent monitoring for lower T-scores
• Rate of bone loss: Faster bone loss warrants more frequent monitoring
• Medication changes: Reassess after starting, stopping, or changing osteoporosis medications
• New fractures: Reassess after any fragility fracture

Before Your DXA Scan

Preparation:

• Calcium supplements: Stop 24 hours before if instructed (can interfere with spine measurements)
• Clothing: Wear loose, comfortable clothing without metal (zippers, buttons, snaps)
• Jewelry: Remove all metal jewelry
• Recent imaging: Tell the technologist if you've recently had:
  • Barium studies (upper GI, barium enema)
  • CT with contrast
  • Nuclear medicine studies
  • These may interfere with DXA measurements

No fasting required: Eat and drink normally before your scan.

Medications: Take your usual medications unless instructed otherwise.

During Your DXA Scan

Positioning:

• Lie on a table: The technologist will position you carefully
• Hip measurement: Your leg will be rotated to visualize the femoral neck properly
• Spine measurement: Your knees may be supported on a cushion to flatten your back
• Stillness: You'll need to lie still for several minutes for each measurement

Duration:

• Total time: 10-20 minutes
• Hip scan: 5-7 minutes
• Spine scan: 5-7 minutes

Comfort:

• Painless: You won't feel anything during the scan
• Open design: No enclosed spaces—most people find DXA comfortable even if claustrophobic

After Your DXA Scan

Immediate recovery:

• No recovery time: You can return to normal activities immediately
• No side effects: No lingering effects from the scan
• Results: Your results will be sent to your referring doctor, typically within a few days

Understanding your results:

• T-score: Most important number for diagnosing osteoporosis
• Z-score: Helps identify secondary causes of bone loss if significantly below zero
• FRAX calculation: Estimates your 10-year fracture risk

Treatment Thresholds

When to treat (general guidelines):

• T-score ≤ -2.5: Osteoporosis—treatment generally recommended
• T-score -1.0 to -2.5 + high FRAX risk: Osteopenia with high fracture risk—treatment may be recommended
• T-score -1.0 to -2.5 + fragility fracture: Treatment recommended
• T-score -1.0 to -2.5 + glucocorticoid use: Treatment often recommended

Individualized decision-making:

• Age: Younger patients with low T-scores may be monitored longer before treating
• Fracture history: Any fragility fracture increases treatment urgency
• Fall risk: Addressing fall risk (home safety, balance exercises) is essential
• Other risk factors: Smoking cessation, limiting alcohol, reviewing medications

Medications That Increase Bone Density

Antiresorptive medications (slow bone loss):

• Bisphosphonates (alendronate, risedronate, zoledronic acid): First-line for most patients
• Denosumab (Prolia): Injection every 6 months
• Hormone therapy (estrogen): For postmenopausal women
• SERMs (raloxifene): Selective estrogen receptor modulators

Anabolic medications (build new bone):

• Teriparatide (Forteo): Daily injection for up to 2 years
• Romosozumab (Evenity): Monthly injection for 1 year
• Abaloparatide (Tymlos): Daily injection for up to 2 years

Monitoring treatment:

• Follow-up DXA: 1-2 years after starting treatment
• Expected improvement: BMD should increase 3-7% at the spine over 1-2 years
• Non-responders: Patients who continue to lose bone despite treatment may need different therapy

Does bone density testing hurt?

No. DXA scanning is completely painless. You'll lie still on a table while the scanner arm passes over you. Some patients experience minor discomfort from lying flat on a hard table, especially if they have back pain, but the scan itself causes no pain.

How often do I need a bone density test?

It depends on your initial results and risk factors:

• Normal BMD: Usually every 10-15 years for postmenopausal women
• Osteopenia: Usually every 2-5 years
• On treatment: Usually every 1-2 years to monitor response
• High risk: More frequent monitoring as determined by your doctor

Can I have osteoporosis with a normal DXA?

Yes, but it's uncommon. A few scenarios:

• Major risk factors: Multiple fragility fractures with normal BMD may warrant treatment
• Secondary osteoporosis: Medications or medical conditions causing bone loss
• Trabecular bone score (TBS): Newer technology assessing bone microarchitecture may identify risk not captured by DXA alone

Does osteoporosis show up on X-ray?

X-rays can show:

• Vertebral compression fractures: Signs of prior osteoporotic fractures
• Decreased bone density: Bones appear more transparent (though this is subjective)

However, X-rays are not reliable for diagnosing osteoporosis because:

• Up to 30-50% bone loss must occur before osteoporosis becomes apparent on X-ray
• Subjective assessment: Different radiologists may disagree
• DXA is more accurate: For measuring bone density

What if my T-score differs between hip and spine?

This is called discordance and is relatively common (about 10-20% of patients). Management is based on:

• Lowest (worst) T-score: Generally used for diagnosis and treatment decisions
• Clinical judgment: Your doctor considers the overall clinical picture, not just the T-score
• Fracture risk assessment: FRAX calculation uses the lowest T-score

Can I stop osteoporosis medication if my DXA improves?

Not necessarily. Osteoporosis is a chronic condition:

• Maintenance may be needed: After stopping anabolic medications, antiresorptive therapy is typically continued
• BMD gains may be lost: Bone density can decrease when medications are stopped
• Fracture protection continues: Medications provide ongoing fracture protection
• Individualized decisions: Discuss medication holidays with your doctor

1. DXA scan is the gold standard for diagnosing osteoporosis, using minimal radiation to measure bone mineral density.

2. T-score interpretation: -1.0 or above is normal, -1.0 to -2.5 indicates osteopenia, and below -2.5 indicates osteoporosis.

3. Each 1 point decrease in T-score approximately doubles fracture risk.

4. Screening is recommended for women over 65 and men over 70, along with younger individuals with risk factors.

5. Vertebral fracture assessment (VFA) detects silent spinal fractures that indicate osteoporosis even when bone density appears normal.

6. FRAX calculation combines DXA with clinical risk factors to estimate 10-year fracture probability and guide treatment decisions.

7. Monitoring interval varies from 1-2 years for treated patients to 10-15 years for those with normal BMD.

8. Treatment thresholds: T-score ≤ -2.5, or T-score -1.0 to -2.5 with high fracture risk or prior fracture.

9. Effective medications can increase bone density 3-7% at the spine over 1-2 years and reduce fracture risk by 30-70%.

10. Osteoporosis is preventable and treatable: Early detection through imaging allows intervention that can prevent debilitating fractures.

Disclaimer: This guide provides general information about osteoporosis imaging. Always consult your healthcare provider for bone health assessment, osteoporosis screening, and treatment recommendations.

Last Updated: March 2026 Next Review: September 2026